company background image
PRO logo

Societe de Promotion Pharmaceutique du Maghreb CBSE:PRO Stock Report

Last Price

د.م984.00

Market Cap

د.م984.0m

7D

0%

1Y

-5.4%

Updated

12 Jun, 2024

Data

Company Financials

Societe de Promotion Pharmaceutique du Maghreb S.A.

CBSE:PRO Stock Report

Market Cap: د.م984.0m

Societe de Promotion Pharmaceutique du Maghreb S.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Societe de Promotion Pharmaceutique du Maghreb
Historical stock prices
Current Share Priceد.م984.00
52 Week Highد.م1,110.00
52 Week Lowد.م921.00
Beta-0.15
1 Month Change3.91%
3 Month Change1.23%
1 Year Change-5.38%
3 Year Change11.82%
5 Year Change23.00%
Change since IPO0.72%

Recent News & Updates

Recent updates

Shareholder Returns

PROMA PharmaceuticalsMA Market
7D0%-1.9%-0.3%
1Y-5.4%16.6%18.8%

Return vs Industry: PRO underperformed the MA Pharmaceuticals industry which returned 16.6% over the past year.

Return vs Market: PRO underperformed the MA Market which returned 18.8% over the past year.

Price Volatility

Is PRO's price volatile compared to industry and market?
PRO volatility
PRO Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement4.0%
Market Average Movement4.6%
10% most volatile stocks in MA Market7.8%
10% least volatile stocks in MA Market2.3%

Stable Share Price: PRO has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine PRO's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1947n/aSalameh Al Araidehwww.promopharm.co.ma

Societe de Promotion Pharmaceutique du Maghreb S.A. produces, commercializes, imports, and exports medicines, derma-pharmaceuticals, and cosmetic products in Africa. It subcontracts medicines for national and international laboratories. The company was founded in 1947 and is headquartered in Had-Soualem, Morocco.

Societe de Promotion Pharmaceutique du Maghreb S.A. Fundamentals Summary

How do Societe de Promotion Pharmaceutique du Maghreb's earnings and revenue compare to its market cap?
PRO fundamental statistics
Market capد.م984.00m
Earnings (TTM)د.م56.90m
Revenue (TTM)د.م805.52m

17.3x

P/E Ratio

1.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PRO income statement (TTM)
Revenueد.م805.52m
Cost of Revenueد.م446.27m
Gross Profitد.م359.24m
Other Expensesد.م302.34m
Earningsد.م56.90m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)56.90
Gross Margin44.60%
Net Profit Margin7.06%
Debt/Equity Ratio27.1%

How did PRO perform over the long term?

See historical performance and comparison

Dividends

4.1%

Current Dividend Yield

65%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.